COMT and Parkinson disease: The clinical course of PD may be characterized by changes in dopamine level, which may be modulated by a combination of two variables: 1) the extent of damage to the dopaminergic system and 2) the activity of COMT enzyme which is coded by a specific genotype in an individual.